| Updated on March 13, 2018 Published on April 04, 2017

Sub: Exercise of option for submission of financial results. Ref: Regulation 33 (3)(b)(1) of SEBI (LODR) Regulations, 2015. With reference to the above cited subject and reference, we would like to inform the exchange that the Company has opted to submit only standalone financial statements to the exchange for the financial year 2017.18. However, both standalone and consolidated financial statements of the Company will be made available on our website i.e www.balpharma.com , as per the provisions of Regulation 33 of SEBI(LODR) Regulations, 2015. Please take this intimation on record. Thanking You.

Pdf Link: Updates

Source : BSE - www.bseindia.com

Published on April 04, 2017
This article is closed for comments.
Please Email the Editor